Senseonics (SENS) Competitors

10x Genomics (NASDAQ:TXG) and Senseonics (NYSE:SENS) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, valuation, earnings, analyst recommendations, profitability, risk, community ranking and dividends.

Is TXG or SENS more profitable?

10x Genomics has a net margin of -29.90% compared to Senseonics' net margin of -362.30%. 10x Genomics' return on equity of -25.40% beat Senseonics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
10x Genomics	-29.90%	-25.40%	-19.69%
Senseonics	-362.30%	-842.25%	-67.99%

Does the media refer more to TXG or SENS?

In the previous week, 10x Genomics had 4 more articles in the media than Senseonics. MarketBeat recorded 6 mentions for 10x Genomics and 2 mentions for Senseonics. Senseonics' average media sentiment score of 1.13 beat 10x Genomics' score of 0.31 indicating that Senseonics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
10x Genomics	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Senseonics	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk and volatility, TXG or SENS?

10x Genomics has a beta of 1.99, suggesting that its share price is 99% more volatile than the S&P 500. Comparatively, Senseonics has a beta of 0.96, suggesting that its share price is 4% less volatile than the S&P 500.

Does the MarketBeat Community favor TXG or SENS?

10x Genomics received 59 more outperform votes than Senseonics when rated by MarketBeat users. Likewise, 50.00% of users gave 10x Genomics an outperform vote while only 17.07% of users gave Senseonics an outperform vote.

Company	Underperform	Outperform
10x Genomics	Outperform Votes 66 50.00%	Underperform Votes 66 50.00%
Senseonics	Outperform Votes 7 17.07%	Underperform Votes 34 82.93%

Do analysts rate TXG or SENS?

10x Genomics currently has a consensus target price of $15.81, indicating a potential upside of 49.13%. Senseonics has a consensus target price of $1.55, indicating a potential upside of 200.85%. Given Senseonics' stronger consensus rating and higher possible upside, analysts clearly believe Senseonics is more favorable than 10x Genomics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
10x Genomics	1 Sell rating(s)	8 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.38
Senseonics	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.50

Do insiders & institutionals hold more shares of TXG or SENS?

84.7% of 10x Genomics shares are held by institutional investors. Comparatively, 12.4% of Senseonics shares are held by institutional investors. 9.4% of 10x Genomics shares are held by insiders. Comparatively, 4.3% of Senseonics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Which has better valuation and earnings, TXG or SENS?

Senseonics has lower revenue, but higher earnings than 10x Genomics. 10x Genomics is trading at a lower price-to-earnings ratio than Senseonics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
10x Genomics	$624.66M	2.09	-$182.63M	-$1.30	-8.15
Senseonics	$23.68M	14.23	-$60.39M	-$0.11	-4.68

Summary

10x Genomics beats Senseonics on 11 of the 19 factors compared between the two stocks.